Clinical Trial Update: A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated cetuximab with chemotherapy as neoadjuvant therapy, followed by concomitant cetuximab-based chemoradiotherapy, in locoregiona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Esophageal Carcinoma | Phase 2 | Status: COMPLETED